LEGACY DIAGNOSTIC LAB LLC NPI 1114539046

NPI Details

LEGACY DIAGNOSTIC LAB LLC is a clinical medical laboratory in Richardson, TX. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. LEGACY DIAGNOSTIC LAB LLC NPI is 1114539046. The provider is registered as an organization entity type.

The provider's business location address is:

1651 N COLLINS BLVD # 135
RICHARDSON, TX
ZIP 75080-658
Phone: (469) 872-0008

The provider's authorized official is Othman Albdour .
The authorized official title is Owner and has the following contact phone number (678) 755-9468.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Molecular pathology procedure level 1 (HCPCS:81400)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence (HCPCS:81223)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants (HCPCS:81291)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (fanconi anemia, complementation group c) common variant (HCPCS:81242)
• Gene analysis (bloom syndrome, recq helicase-like) (HCPCS:81209)
• Gene analysis (partner and localizer of brca2) full sequence analysis (HCPCS:81307)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 (HCPCS:81339)
• Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis (HCPCS:81249)
• Gene analysis (glucose-6-phosphatase, catalytic subunit) common variants (HCPCS:81250)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (muts homolog 6 [e coli]) full sequence analysis (HCPCS:81298)
• Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis (HCPCS:81317)
• Gene analysis (tata box binding protein) for abnormal alleles (HCPCS:81344)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Molecular pathology procedure level 2 (HCPCS:81401)
• Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes (HCPCS:81410)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Test for detecting genes associated with heart disease, duplication/deletion analysis panel, at least 2 genes (HCPCS:81414)
• Gene analysis (frataxin) of full sequence (HCPCS:81286)

The enumeration date for this NPI number is 8/21/2020 and was last updated on 4/12/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: